Share

December 11, 2018; 91 (24) Article

White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease

Ian O. Bledsoe, Glenn T. Stebbins, Doug Merkitch, Jennifer G. Goldman
First published November 14, 2018, DOI: https://doi.org/10.1212/WNL.0000000000006646
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
200

Share

Article Information

vol. 91 no. 24 e2244-e2255
DOI: 
https://doi.org/10.1212/WNL.0000000000006646
PubMed: 
30429273
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received April 2, 2018
  • Accepted in final form August 23, 2018
  • First Published November 14, 2018.

Article Versions

Copyright & Usage: 
© 2018 American Academy of Neurology

Author Disclosures

    1. Ian O. Bledsoe, MD, MS,
    2. Glenn T. Stebbins, PhD,
    3. Doug Merkitch, BA and
    4. Jennifer G. Goldman, MD, MS
  1. Ian O. Bledsoe, MD, MS,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant, Bagatto, Inc.

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. (1) Unum Group, Independent Medical Examination

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Glenn T. Stebbins, PhD,
    3. Scientific Advisory Boards:

    1. 1. Ultragenyx Pharmaceutical 2. Medgenesis 3. Cleveland Clinic Foundation

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1. International Parkinson and Movement Disorder Society - Travel 2. Dystonia Coalition - Travel 3. American Academy of Neurology - Honoraria 4. Michael J. Fox Foundation for Parkinson's Research - Honoraria 5. Food and Drug Administration - Honoraria 6. National Institutes of Health - Honoraria 7. TOXINS - Travel 8. American Society for Experimental Neurotherapeutics - Travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. 1. Acadia Pharmaceuticals 2. Adamas Pharmaceuticals, Inc. 3. Ceregene, Inc. 4. CHDI Management, Inc. 5. Ingenix Pharmaceutical Services (i3 Research) 6. Neurocrine Biosciences, Inc. 7. Pfizer, Inc. 8. Tool-4-Patient

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 1. US Army Medical Research and Materiel Command, PR161108, Co-I, 2017- 2022

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1. Michael J. Fox Foundation for Parkinson's Research 2. CHDI 3. Dystonia Coalition 4. International Parkinson and Movement Disorder Society 5. CBD Solution

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Doug Merkitch, BA and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J. Fox Foundation (research study, PI Goldman)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Jennifer G. Goldman, MD, MS
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) Movement Disorder Society (travel, honoraria), 2) American Academy of Neurology (travel)

    Editorial Boards:

    1. 1) Movement Disorders Journal, Editorial board member, 2015-present; 2) Journal of Clinical Movement Disorders, Editorial board member, 2014- present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Rush University Medical Center, Chicago, IL

    Consultancies:

    1. 1) Acadia, 2) Aptinyx

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Acadia, Biotie/Accorda (clinical trial site-PI)

    Research Support, Government Entities:

    1. NIH/NINDS, K23NS060949, PI, 2008-2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Michael J. Fox Foundation, Parkinson's Disease Foundation, Consolidated Anti-Aging, Parkinson's Foundation, CHDI, HDSA

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Movement Disorder and Neuromodulation Center (I.O.B.), Department of Neurology, University of California, San Francisco; and the Section of Parkinson Disease and Movement Disorders (G.T.S., D.M., J.G.G.), Department of Neurological Sciences, Rush University Medical Center, Chicago, IL.
  1. Correspondence
    Dr. Goldman drjennifergoldman{at}gmail.com
View Full Text

Article usage

Article usage: November 2018 to February 2020

AbstractFullPdfSource
Nov 2018317032Highwire
Dec 2018134012872Highwire
Jan 20192781820Highwire
Feb 20191871713Highwire
Mar 2019237811Highwire
Apr 201911766Highwire
May 201910948Highwire
Jun 20198097Highwire
Jul 20198953Highwire
Aug 20197257Highwire
Sep 20199228Highwire
Oct 20194921Highwire
Nov 20198055Highwire
Dec 20194132Highwire
Jan 20203843Highwire
Feb 20205112Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

More Online

CME Course

Topics Discussed

Alert Me